Filter
7182
Filtered Results: 7182
Text search:
Public
Health
and
social
measures
Featured
Recommendations
610
New Publications
1898
Language
Document type
No document type
3987
Studies & Reports
1354
Guidelines
814
Manuals
356
Strategic & Response Plan
304
Fact sheets
161
Training Material
88
Situation Updates
73
Resource Platforms
16
Brochures
13
Infographics
9
Online Courses
6
App
1
Countries / Regions
Global
314
India
289
Kenya
220
Liberia
157
Ethiopia
154
South Africa
153
Western and Central Europe
153
Sierra Leone
152
Nepal
145
Nigeria
132
Uganda
131
Myanmar / Burma
125
Tanzania
110
Rwanda
109
Latin America and the Carribbean
109
Syria
102
Zambia
101
Bangladesh
101
Africa
100
Malawi
90
Ghana
89
Ukraine
82
Congo, Democratic Republic of
78
Namibia
71
Philippines
69
South–East Asia Region
55
Eastern Europe
55
Cambodia
53
Indonesia
53
Zimbabwe
51
South Sudan
50
Brazil
50
Guinea
49
Lesotho
47
West and Central Africa
47
Asia
46
Yemen
45
Mozambique
44
East and Southern Africa
42
Middle East and North Africa
40
Senegal
37
Russia
37
Haiti
34
Germany
33
Venezuela
33
Botswana
32
Pakistan
31
Eastern Europe and Central Asia
31
Afghanistan
30
Cameroon
28
Burkina Faso
26
Colombia
25
Jordan
21
Lebanon
21
Sudan
20
Eswatini/ Swaziland
20
Western Pacific Region
20
Vietnam
20
Mali
18
Somalia
17
Central African Republic
17
Tajikistan
16
Thailand
15
China
15
Iraq
14
Moldova
14
Madagascar
13
Laos
13
Benin
12
Palestine
12
USA
11
Chile
10
Albania
10
Iran
10
Burundi
9
Angola
9
Sri Lanka
9
Paraguay
9
Georgia
9
Côte d’Ivoire / Ivory Coast
7
Turkey
7
Egypt
7
Argentina
7
Peru
7
Ecuador
7
Mexico
7
Southern Africa
7
Guinea-Bissau
6
Niger
6
Papua New Guinea
6
North Macedonia
6
Greece
6
Libya
6
Kyrgyzstan
6
Jamaica
6
Togo
5
Gambia
5
Malaysia
5
Bolivia
5
Poland
5
Kazakhstan
5
Turkmenistan
5
United Kingdom
5
Portugal
5
Spain
5
Saudi Arabia
4
Hungary
4
El Salvador
4
Timor Leste/ East Timor
4
Romania
4
North America
4
Tunisia
4
Morocco
3
Chad
3
Singapore
3
Serbia
3
Croatia
3
Honduras
3
Guatemala
3
Italy
3
Armenia
3
Canada
3
Estonia
3
Uzbekistan
3
Japan
3
Mauritius
3
Bosnia and Herzegovina
3
Other region
2
Fiji
2
Bhutan
2
Mongolia
2
Qatar
2
France
2
Azerbaijan
2
Belarus
2
Israel
2
Mauritania
1
Ireland
1
Vanuatu
1
Dominican Republic
1
Switzerland
1
Nicaragua
1
Solomon Islands
1
North Korea
1
Djibouti
1
Congo-Brazzaville
1
Bulgaria
1
Lithuania
1
Slovakia
1
Gabon
1
Maldives
1
Norway
1
South Korea
1
Algeria
1
Morocco
1
French Guyana
1
Authors & Publishers
Publication Years
Category
Countries
2861
Public Health
401
Clinical Guidelines
341
Key Resources
335
Women & Child Health
310
Capacity Building
99
Pharmacy & Technologies
22
Annual Report MEDBOX
1
Toolboxes
COVID-19
909
Mental Health
562
HIV
466
Disability
333
Planetary Health
325
TB
284
Ebola
238
Conflict
216
Rapid Response
204
Refugee
168
Caregiver
157
Global Health Education
144
AMR
140
NTDs
129
NCDs
116
Natural Hazards
104
Health Financing Toolbox
75
Pharmacy
70
Polio
44
Cholera
40
Zika
39
Specific Hazards
36
Social Ethics
28
Typhoon
4
Health Financing
2
South Sudan
1
The Pandemic Influenza Preparedness (PIP) Framework is a World Health Assembly resolution adopted unanimously by all Member States in 2011. It brings together Member States, industry, other stakeholders an... WHO to implement a global approach to pandemic influenza preparedness and response. The Framework includes a benefit-sharing mechanism called the Partnership Contribution (PC). The PC is collected as an annual cash contribution from influenza vaccine, diagnostic, and pharmaceutical manufacturers that use the WHO Global Influenza Surveillance and Response System (GISRS). Funds are allocated for: (a) pandemic preparedness capacity building; (b) response activities during the time of an influenza pandemic; and (c) PIP Secretariat for the management and implementation of the Framework.
Le présent document est une mise à jour du document d’information scientifique publié le 29 mars 2020 intitulé Modes of transmission of virus causing COVID-19: implications for infection prevention and control (IPC) precauti...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary include...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence s...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included...
12 May 2021. This third survey in the series shows that the COVID-19 pandemic continues to impact societies, not only in terms of health, but also social ... economic conditions and day-to-day life
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immu...
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s...
The main objective of this mission was to assess the level of preparedness of Guinea-Bissau in respect of the WHO consolidated checklist. The checklist helps countries to assess and test their level of readiness it is being used to identify concrete...
These consolidated guidelines on HIV testing services (HTS) bring together existing and new guidance on HTS across different settings and populations.
The World ... Organization (WHO) first released consolidated guidelines on HTS in 2015, in response to requests from Member States, national programme managers and health workers for support to achieve the United Nations (UN) 90–90–90 global HIV targets – and specifically the first target of diagnosing 90% of all people with HIV. In 2016, based on new evidence, WHO released a supplement to address important new HIV testing approaches – HIV self-testing (HIVST) and provider-assisted referral.
Since the release of 2015 and 2016 HTS guidelines, new issues and more evidence have emerged. To address this, WHO has updated guidance on HIV testing services. In this guideline, WHO updates recommendation on HIVST and provides new recommendations on social network-based HIV testing approaches and western blotting (see box, next page). This guideline seeks to provide support to Member States, programme managers, health workers and other stakeholders seeking to achieve national and international goals to end the HIV epidemic as a public health threat by 2030.
These guidelines also provide operational guidance on HTS demand creation and messaging; implementation considerations for priority populations; HIV testing strategies for diagnosis HIV; optimizing the use of dual HIV/syphilis rapid diagnostic tests; and considerations for strategic planning and rationalizing resources such as optimal time points for maternal retesting
People with underlying noncommunicable diseases (NCDs) such as hypertension, diabetes, cardiovascular disease, chronic respiratory disease and cancer have a high risk for developing severe and even ...
HIV testing programmes need to ensure that all clients who test for HIV are provided with correct diagnoses. The accuracy of HIV testing is critical to prevent misdiagnosis, as the consequences of giving an incorrect test result can be serious for clients, HIV testing services, HIV programmes ... public health.
With the evolution of global HIV epidemiology, HIV testing approaches must also evolve to maintain accuracy and efficiency in population-level diagnosis. Reports suggest that misdiagnosis of HIV status may occur when suboptimal testing algorithms and out-of-date testing strategies are used. As a result of changing epidemiology and declining HIV positivity in testing, WHO recommends all countries use a standard three-test strategy to ensure a PPV of at least 99%, minimizing false-positive misdiagnosis. The WHO-recommended HIV testing strategy, along with quality assurance measures such as retesting to verify a positive diagnosis prior to initiation of HIV treatment, is cost-effective as it prevents misdiagnosis and unnecessary initiation of costly lifelong treatment.
This implementation guide provides practical advice on switching to a three-test strategy and instituting other measures that can help national HIV programmes deliver high-quality, accurate HIV testing services and ensure that misdiagnosis is minimized.
In an effort to limit transmission and achieve pandemic control on the continent, Africa CDC is proposing the following measures to be taken by all Member States:
Remain vigilant
Countries shoul...
This report is the first of its kind. It brings together various data sets to present the current status of hand hygiene, highlight lagging progress, and call governments and supporting agencies to ...
The number of COVID-19 cases is on the rise again, with South Africa nearing half of all confirmed cases in the WHO African Region. Threats of new variants loom and low vaccination coverage raises questions on the future of the response to COVID-19....
Bonchial asthma is the most common chronic respiratory disease in the world. In Kenya, it has been estimated that about 7.5% of the Kenyan population, nearly 4 million people, are currently living with asthma. Many cases tend to be underdiagnosed and...
Disabled children: a legal handbook is an authoritative yet accessible guide to the legal rights of disabled children and their families in England and Wales. The handbook aims to empower disabled ...
The Pandemic Influenza Pandemic (PIP) Framework's Partnership Contribution (PC) High-Level Implementation Plan III (HLIP III) outlines the strategy for strengthening global pandemic influenza preparedness from 2024 to 2030. HLIP III takes into consideration the lessons learned from the response to t...
The coronavirus outbreak that began in 2019 (COVID-19) threatens to reverse years of hard-won gains in preventing and treating HIV. Fragile health systems are further stressed as ... workers navigate an increased client load and demands at work while also being concerned for their own health and that of their families. Health facilities have been redesigned to care for patients with COVID-19, posing challenges to other services. Governments and civil society organizations have redirected scarce resources and shifted programming priorities to respond to the pandemic. Several countries have reported intermittent declines in HIV testing and diagnosis, antenatal care visits, collection of antiretroviral medicines (ARVs) by people living with HIV, and attendance at clinic appointments. Community-based education and support programmes have had to rapidly adapt to restrictions on movement and public gatherings. Children, adolescents, and women have experienced multiple deprivations due to the adverse impact of the pandemic.
This report offers a summary of the provided support and recommendations on priority activities for IPC improvement at national and facility levels. The COVID-19 pandemic spotlighted areas for impro...
